Quantification of domperidone, paracetamol, esomeprazole and lansoprazole in pharmaceutical dosage forms by reversed phase high performance liquid chromatography

S. G. Vasantharaju, P. Namita, Syed Sajjad Hussen

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

A simple, sensitive, and accurate high performance liquid chromatographic method developed and validated for the simultaneous estimation of domperidone, paracetamol, esomeprazole, and lansoprazole in pharmaceutical dosage forms.The assay involved the use of photo diode array detection at 285 nm for domperidone, 246 nm for paracetamol, 300 nm for esomeprazole, and 283 nm for lansoprazole. The compounds were well separated on a Supelco C18 (250×4.6mm,5μ) reversed-phase column and mobile phase consisting of 0.01 M, pH 7.00, dipotassium hydrogen phosphate buffer - acetonitrile (65:35 v/v) at a flow rate of 1.0 mL min-1. The linearity range was 0.5 - 50 μg mL-1 for all the four analytes domperidone, paracetamol, esomeprazole and lansoprazole. Limits of detection (LOD) obtained were 0.1 μg mL-1 for each of the four drugs. The developed analytical method was validated as per ICHQ2 (R1) guidance. Study showed that reversed-phase liquid chromatography is sensitive and selective for the determination of domperidone, paracetamol, esomeprazole, and lansoprazole in pharmaceutical dosage forms.

Original languageEnglish
Pages (from-to)303-306
Number of pages4
JournalInternational Journal of Pharmacy and Pharmaceutical Sciences
Volume4
Issue numberSUPPL.3
Publication statusPublished - 26-06-2012

Fingerprint

Esomeprazole
Lansoprazole
Domperidone
Dosage Forms
Reverse-Phase Chromatography
Acetaminophen
High Pressure Liquid Chromatography
Pharmaceutical Preparations
Limit of Detection
Buffers

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science

Cite this

@article{e2505ae9c520419b8067a1886ba07fc9,
title = "Quantification of domperidone, paracetamol, esomeprazole and lansoprazole in pharmaceutical dosage forms by reversed phase high performance liquid chromatography",
abstract = "A simple, sensitive, and accurate high performance liquid chromatographic method developed and validated for the simultaneous estimation of domperidone, paracetamol, esomeprazole, and lansoprazole in pharmaceutical dosage forms.The assay involved the use of photo diode array detection at 285 nm for domperidone, 246 nm for paracetamol, 300 nm for esomeprazole, and 283 nm for lansoprazole. The compounds were well separated on a Supelco C18 (250×4.6mm,5μ) reversed-phase column and mobile phase consisting of 0.01 M, pH 7.00, dipotassium hydrogen phosphate buffer - acetonitrile (65:35 v/v) at a flow rate of 1.0 mL min-1. The linearity range was 0.5 - 50 μg mL-1 for all the four analytes domperidone, paracetamol, esomeprazole and lansoprazole. Limits of detection (LOD) obtained were 0.1 μg mL-1 for each of the four drugs. The developed analytical method was validated as per ICHQ2 (R1) guidance. Study showed that reversed-phase liquid chromatography is sensitive and selective for the determination of domperidone, paracetamol, esomeprazole, and lansoprazole in pharmaceutical dosage forms.",
author = "Vasantharaju, {S. G.} and P. Namita and Hussen, {Syed Sajjad}",
year = "2012",
month = "6",
day = "26",
language = "English",
volume = "4",
pages = "303--306",
journal = "International Journal of Pharmacy and Pharmaceutical Sciences",
issn = "0975-1491",
publisher = "IJPPS",
number = "SUPPL.3",

}

TY - JOUR

T1 - Quantification of domperidone, paracetamol, esomeprazole and lansoprazole in pharmaceutical dosage forms by reversed phase high performance liquid chromatography

AU - Vasantharaju, S. G.

AU - Namita, P.

AU - Hussen, Syed Sajjad

PY - 2012/6/26

Y1 - 2012/6/26

N2 - A simple, sensitive, and accurate high performance liquid chromatographic method developed and validated for the simultaneous estimation of domperidone, paracetamol, esomeprazole, and lansoprazole in pharmaceutical dosage forms.The assay involved the use of photo diode array detection at 285 nm for domperidone, 246 nm for paracetamol, 300 nm for esomeprazole, and 283 nm for lansoprazole. The compounds were well separated on a Supelco C18 (250×4.6mm,5μ) reversed-phase column and mobile phase consisting of 0.01 M, pH 7.00, dipotassium hydrogen phosphate buffer - acetonitrile (65:35 v/v) at a flow rate of 1.0 mL min-1. The linearity range was 0.5 - 50 μg mL-1 for all the four analytes domperidone, paracetamol, esomeprazole and lansoprazole. Limits of detection (LOD) obtained were 0.1 μg mL-1 for each of the four drugs. The developed analytical method was validated as per ICHQ2 (R1) guidance. Study showed that reversed-phase liquid chromatography is sensitive and selective for the determination of domperidone, paracetamol, esomeprazole, and lansoprazole in pharmaceutical dosage forms.

AB - A simple, sensitive, and accurate high performance liquid chromatographic method developed and validated for the simultaneous estimation of domperidone, paracetamol, esomeprazole, and lansoprazole in pharmaceutical dosage forms.The assay involved the use of photo diode array detection at 285 nm for domperidone, 246 nm for paracetamol, 300 nm for esomeprazole, and 283 nm for lansoprazole. The compounds were well separated on a Supelco C18 (250×4.6mm,5μ) reversed-phase column and mobile phase consisting of 0.01 M, pH 7.00, dipotassium hydrogen phosphate buffer - acetonitrile (65:35 v/v) at a flow rate of 1.0 mL min-1. The linearity range was 0.5 - 50 μg mL-1 for all the four analytes domperidone, paracetamol, esomeprazole and lansoprazole. Limits of detection (LOD) obtained were 0.1 μg mL-1 for each of the four drugs. The developed analytical method was validated as per ICHQ2 (R1) guidance. Study showed that reversed-phase liquid chromatography is sensitive and selective for the determination of domperidone, paracetamol, esomeprazole, and lansoprazole in pharmaceutical dosage forms.

UR - http://www.scopus.com/inward/record.url?scp=84862599152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862599152&partnerID=8YFLogxK

M3 - Article

VL - 4

SP - 303

EP - 306

JO - International Journal of Pharmacy and Pharmaceutical Sciences

JF - International Journal of Pharmacy and Pharmaceutical Sciences

SN - 0975-1491

IS - SUPPL.3

ER -